Literature DB >> 32975722

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.

Xiao Meng1,2, Ya Liu3, Chenchen Wei1, Kai Zhang1,2, Yi Zhang2,4, Ming Zhong1, Cheng Zhang5, Yun Zhang6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32975722      PMCID： PMC7518094          DOI： 10.1007/s11427-020-1813-0

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
Supplementary material, approximately 27.5 KB.
  11 in total

1.  Effects of an angiotensin-converting enzyme inhibitor (ramipril) on inflammatory markers in secondary prevention patients: RAICES Study.

Authors:  Ricardo G Lopez Santi; Eduardo C Valeff; Claudio R Duymovich; Daniel Mazziotta; Norma E Mijailovsky; Gerardo C Filippa; Raúl Maltez; Violeta A Hernandez; Alejandro Gomez Monroy; Jorge G Borzi; Rosana A Acheme; María C Etchegoyen
Journal:  Coron Artery Dis       Date:  2005-11       Impact factor: 1.439

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.

Authors:  Luke J Burchill; Elena Velkoska; Rachael G Dean; Karen Griggs; Sheila K Patel; Louise M Burrell
Journal:  Clin Sci (Lond)       Date:  2012-12       Impact factor: 6.124

4.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Authors:  Lei Fang; George Karakiulakis; Michael Roth
Journal:  Lancet Respir Med       Date:  2020-03-11       Impact factor: 30.700

5.  [Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？].

Authors:  J M Yang; X Meng; F Xue; Y Zhang; C Zhang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2020-07-24

6.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

Review 9.  Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.

Authors:  Fan Jiang; Jianmin Yang; Yongtao Zhang; Mei Dong; Shuangxi Wang; Qunye Zhang; Fang Fang Liu; Kai Zhang; Cheng Zhang
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 49.421

Review 10.  Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.

Authors:  Yajing Fu; Yuanxiong Cheng; Yuntao Wu
Journal:  Virol Sin       Date:  2020-03-03       Impact factor: 4.327
View more
  5 in total

Review 1.  Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.

Authors:  Jordan Loader; Frances C Taylor; Erik Lampa; Johan Sundström
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

2.  Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium.

Authors:  José L Peñalvo; Els Genbrugge; Elly Mertens; Diana Sagastume; Marianne A B van der Sande; Marc-Alain Widdowson; Dominique Van Beckhoven
Journal:  BMJ Open       Date:  2021-09-16       Impact factor: 3.006

3.  The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review.

Authors:  Hiba Naveed; Abdallah Elshafeey; Dana Al-Ali; Emmad Janjua; Areej Nauman; Hussam Kawas; Ridhima Kaul; Arwa Saed Aldien; Mohamed B Elshazly; Dalia Zakaria
Journal:  J Clin Pharmacol       Date:  2021-04-07       Impact factor: 2.860

Review 4.  The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review.

Authors:  Farnoosh Nozari; Nasrin Hamidizadeh
Journal:  Int J Hypertens       Date:  2022-01-21       Impact factor: 2.420

5.  Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.

Authors:  Álvaro Aparisi; Pablo Catalá; Ignacio J Amat-Santos; Marta Marcos-Mangas; Diego López-Otero; Carlos Veras; Javier López-Pais; Gonzalo Cabezón-Villalba; Carla Eugenia Cacho Antonio; Jordi Candela; Pablo Antúnez-Muiños; José Francisco Gil; Teba González Ferrero; Gino Rojas; Marta Pérez-Poza; Aitor Uribarri; Oscar Otero-García; Pablo Elpidio García-Granja; Víctor Jiménez Ramos; Ana Revilla; Carlos Dueñas; Itzíar Gómez; José Ramón González-Juanatey; J Alberto San Román
Journal:  Med Clin (Engl Ed)       Date:  2022-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.